Progress in gene therapy for neurological disorders

Michele Simonato, Jean Bennett, Nicholas M. Boulis, Maria G. Castro, David J. Fink, William F. Goins, Steven J. Gray, Pedro R. Lowenstein, Luk H. Vandenberghe, Thomas J. Wilson, John H. Wolfe, Joseph C. Glorioso

Research output: Contribution to journalReview article

115 Citations (Scopus)

Abstract

Diseases of the nervous system have devastating effects and are widely distributed among the population, being especially prevalent in the elderly. These diseases are often caused by inherited genetic mutations that result in abnormal nervous system development, neurodegeneration, or impaired neuronal function. Other causes of neurological diseases include genetic and epigenetic changes induced by environmental insults, injury, disease-related events or inflammatory processes. Standard medical and surgical practice has not proved effective in curing or treating these diseases, and appropriate pharmaceuticals do not exist or are insufficient to slow disease progression. Gene therapy is emerging as a powerful approach with potential to treat and even cure some of the most common diseases of the nervous system. Gene therapy for neurological diseases has been made possible through progress in understanding the underlying disease mechanisms, particularly those involving sensory neurons, and also by improvement of gene vector design, therapeutic gene selection, and methods of delivery. Progress in the field has renewed our optimism for gene therapy as a treatment modality that can be used by neurologists, ophthalmologists and neurosurgeons. In this Review, we describe the promising gene therapy strategies that have the potential to treat patients with neurological diseases and discuss prospects for future development of gene therapy.

Original languageEnglish (US)
Pages (from-to)277-291
Number of pages15
JournalNature Reviews Neurology
Volume9
Issue number5
DOIs
StatePublished - May 1 2013

Fingerprint

Nervous System Diseases
Genetic Therapy
Inborn Genetic Diseases
Sensory Receptor Cells
Epigenomics
Nervous System
Genes
Disease Progression
Mutation
Wounds and Injuries
Therapeutics
Pharmaceutical Preparations
Population

ASJC Scopus subject areas

  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

Simonato, M., Bennett, J., Boulis, N. M., Castro, M. G., Fink, D. J., Goins, W. F., ... Glorioso, J. C. (2013). Progress in gene therapy for neurological disorders. Nature Reviews Neurology, 9(5), 277-291. https://doi.org/10.1038/nrneurol.2013.56

Progress in gene therapy for neurological disorders. / Simonato, Michele; Bennett, Jean; Boulis, Nicholas M.; Castro, Maria G.; Fink, David J.; Goins, William F.; Gray, Steven J.; Lowenstein, Pedro R.; Vandenberghe, Luk H.; Wilson, Thomas J.; Wolfe, John H.; Glorioso, Joseph C.

In: Nature Reviews Neurology, Vol. 9, No. 5, 01.05.2013, p. 277-291.

Research output: Contribution to journalReview article

Simonato, M, Bennett, J, Boulis, NM, Castro, MG, Fink, DJ, Goins, WF, Gray, SJ, Lowenstein, PR, Vandenberghe, LH, Wilson, TJ, Wolfe, JH & Glorioso, JC 2013, 'Progress in gene therapy for neurological disorders', Nature Reviews Neurology, vol. 9, no. 5, pp. 277-291. https://doi.org/10.1038/nrneurol.2013.56
Simonato M, Bennett J, Boulis NM, Castro MG, Fink DJ, Goins WF et al. Progress in gene therapy for neurological disorders. Nature Reviews Neurology. 2013 May 1;9(5):277-291. https://doi.org/10.1038/nrneurol.2013.56
Simonato, Michele ; Bennett, Jean ; Boulis, Nicholas M. ; Castro, Maria G. ; Fink, David J. ; Goins, William F. ; Gray, Steven J. ; Lowenstein, Pedro R. ; Vandenberghe, Luk H. ; Wilson, Thomas J. ; Wolfe, John H. ; Glorioso, Joseph C. / Progress in gene therapy for neurological disorders. In: Nature Reviews Neurology. 2013 ; Vol. 9, No. 5. pp. 277-291.
@article{0ba8d62169e04cdbae7f45c8f9d7a3a0,
title = "Progress in gene therapy for neurological disorders",
abstract = "Diseases of the nervous system have devastating effects and are widely distributed among the population, being especially prevalent in the elderly. These diseases are often caused by inherited genetic mutations that result in abnormal nervous system development, neurodegeneration, or impaired neuronal function. Other causes of neurological diseases include genetic and epigenetic changes induced by environmental insults, injury, disease-related events or inflammatory processes. Standard medical and surgical practice has not proved effective in curing or treating these diseases, and appropriate pharmaceuticals do not exist or are insufficient to slow disease progression. Gene therapy is emerging as a powerful approach with potential to treat and even cure some of the most common diseases of the nervous system. Gene therapy for neurological diseases has been made possible through progress in understanding the underlying disease mechanisms, particularly those involving sensory neurons, and also by improvement of gene vector design, therapeutic gene selection, and methods of delivery. Progress in the field has renewed our optimism for gene therapy as a treatment modality that can be used by neurologists, ophthalmologists and neurosurgeons. In this Review, we describe the promising gene therapy strategies that have the potential to treat patients with neurological diseases and discuss prospects for future development of gene therapy.",
author = "Michele Simonato and Jean Bennett and Boulis, {Nicholas M.} and Castro, {Maria G.} and Fink, {David J.} and Goins, {William F.} and Gray, {Steven J.} and Lowenstein, {Pedro R.} and Vandenberghe, {Luk H.} and Wilson, {Thomas J.} and Wolfe, {John H.} and Glorioso, {Joseph C.}",
year = "2013",
month = "5",
day = "1",
doi = "10.1038/nrneurol.2013.56",
language = "English (US)",
volume = "9",
pages = "277--291",
journal = "Nature Reviews Neurology",
issn = "1759-4758",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Progress in gene therapy for neurological disorders

AU - Simonato, Michele

AU - Bennett, Jean

AU - Boulis, Nicholas M.

AU - Castro, Maria G.

AU - Fink, David J.

AU - Goins, William F.

AU - Gray, Steven J.

AU - Lowenstein, Pedro R.

AU - Vandenberghe, Luk H.

AU - Wilson, Thomas J.

AU - Wolfe, John H.

AU - Glorioso, Joseph C.

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Diseases of the nervous system have devastating effects and are widely distributed among the population, being especially prevalent in the elderly. These diseases are often caused by inherited genetic mutations that result in abnormal nervous system development, neurodegeneration, or impaired neuronal function. Other causes of neurological diseases include genetic and epigenetic changes induced by environmental insults, injury, disease-related events or inflammatory processes. Standard medical and surgical practice has not proved effective in curing or treating these diseases, and appropriate pharmaceuticals do not exist or are insufficient to slow disease progression. Gene therapy is emerging as a powerful approach with potential to treat and even cure some of the most common diseases of the nervous system. Gene therapy for neurological diseases has been made possible through progress in understanding the underlying disease mechanisms, particularly those involving sensory neurons, and also by improvement of gene vector design, therapeutic gene selection, and methods of delivery. Progress in the field has renewed our optimism for gene therapy as a treatment modality that can be used by neurologists, ophthalmologists and neurosurgeons. In this Review, we describe the promising gene therapy strategies that have the potential to treat patients with neurological diseases and discuss prospects for future development of gene therapy.

AB - Diseases of the nervous system have devastating effects and are widely distributed among the population, being especially prevalent in the elderly. These diseases are often caused by inherited genetic mutations that result in abnormal nervous system development, neurodegeneration, or impaired neuronal function. Other causes of neurological diseases include genetic and epigenetic changes induced by environmental insults, injury, disease-related events or inflammatory processes. Standard medical and surgical practice has not proved effective in curing or treating these diseases, and appropriate pharmaceuticals do not exist or are insufficient to slow disease progression. Gene therapy is emerging as a powerful approach with potential to treat and even cure some of the most common diseases of the nervous system. Gene therapy for neurological diseases has been made possible through progress in understanding the underlying disease mechanisms, particularly those involving sensory neurons, and also by improvement of gene vector design, therapeutic gene selection, and methods of delivery. Progress in the field has renewed our optimism for gene therapy as a treatment modality that can be used by neurologists, ophthalmologists and neurosurgeons. In this Review, we describe the promising gene therapy strategies that have the potential to treat patients with neurological diseases and discuss prospects for future development of gene therapy.

UR - http://www.scopus.com/inward/record.url?scp=84877578223&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877578223&partnerID=8YFLogxK

U2 - 10.1038/nrneurol.2013.56

DO - 10.1038/nrneurol.2013.56

M3 - Review article

C2 - 23609618

AN - SCOPUS:84877578223

VL - 9

SP - 277

EP - 291

JO - Nature Reviews Neurology

JF - Nature Reviews Neurology

SN - 1759-4758

IS - 5

ER -